Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Description

Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.

Conditions

Autism Spectrum Disorder, Autism, Asperger Syndrome

Study Overview

Study Details

Study overview

Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Condition
Autism Spectrum Disorder
Intervention / Treatment

-

Contacts and Locations

Stanford

Stanford University, Stanford, California, United States, 94305-5719

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Diagnosis of Autism Spectrum Disorder (ASD), Asperger's or Autism.
  • 2. Meet criteria for ASD on clinical assessments (ADOS-2 or CARS/BOSA if conducted remotely \& ADI-R)
  • 3. Aged between 12-45 years old
  • 4. Have a reliable informant who can complete relevant questionnaires
  • 5. Must have previously not responded or not tolerated 2 treatments.
  • 1. Any contraindications for TMS e.g. history of seizures
  • 2. Pregnancy
  • 3. Any current or past history of any physical condition which in the investigator's opinion might put the subject at risk or interfere with study results interpretation.
  • 4. Active substance use (\<1 week) or intoxication verified by toxicology screen--of cocaine, amphetamines, benzodiazepines
  • 5. Showing symptoms of withdrawal from alcohol or benzodiazepines
  • 6. DSM-5 diagnosis of bipolar disorder or a psychotic disorder e.g. schizophrenia.
  • 7. Significant sensory impairments such as blindness or deafness.
  • 8. Any other indication the PI feels would comprise data
  • 9. Current severe insomnia (must sleep a minimum of 4 hours the night before stimulation)
  • 10. IQ\<50 or not testable using IQ measures and no historical IQ score available
  • 11. Currently taking Clozapine or another medication that the PI determines increases the risk of TMS or may disrupt the efficacy.
  • 12. A motor threshold that is too high to allow safe/tolerable treatment.

Ages Eligible for Study

12 Years to 45 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Antonio Y. Hardan, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2027-03-01